New Releases from NCBI BookshelfEvolocumab (Repatha): Therapeutic area: Primary hyperlipidemia: Reimbursement Review [Internet].Evolocumab (Repatha): Therapeutic area: Primary hyperlipidemia: Reimbursement Review [Internet].
Post Content
VA Pain Management, Opioid Safety and Prescription Drug Monitoring Program, and VA Physical Medicine and Rehabilitation are coleading an Integrated
In April, HHS and DOL released recommendations to improve data infrastructure on the workforce delivering HCBS in response to President
There is a need to identify drugs currently in development (pipeline drugs) intended to prevent or treat influenza.
To review the evidence on screening for osteoporosis to prevent fractures in community-dwelling adults in primary care settings.
Placement of a ventriculoperitoneal (VP) shunt for hydrocephalus is the most common procedure performed by pediatric neurosurgeons. Shunts are the
This systematic review was conducted by the 2025 Dietary Guidelines Advisory Committee as part of the process to develop the
Canada’s Drug Agency (CDA-AMC) recommends that Fruzaqla should be reimbursed by public drug plans for the treatment of adult patients